Cordlife stands firm on offer price for StemLife as deadline looms


One of the cryo containers that store umbilical cord blood and bone marrow samples at the private cord blood bank StemLife Bhd in Kuala Lumpur. The samples are kept in the stacked metal boxes to the left of the cylinder.

If Cordlife gets less than 90%, Bursa Securities may impose additional conditions for the withdrawal of StemLife’s listing status. A listed company also may not withdraw its listing unless, among others, the withdrawal resolution must be made at an EGM where it is approved by 75% in value of shareholders and holders of any other class of listed securities.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Pensonic shareholder initiates EGM to remove group CEO
CPE Tech enters into JV with Japanese firm
Insights Analytics unit secures maintenance contract
Stratus Global's IPO oversubscribed 128.82 times ahead of Bursa debut
Moody's affirms Malaysia's A3 rating, expects strongest growth among peers in 2026, says MOF
Paragon Globe proposes RM127.28mil Sedenak acquisition
Ringgit ends lower against US dollar amid cautious sentiment
Fibromat bags RM140mil road construction job
TSR Capital wins RM130mil highway job
Malaysia retains top spot in Southeast Asia IPO market in 1H26, says Deloitte

Others Also Read